IR Library | Astellas

Investor Relations Library

IR Calendar

Upcoming events

Event

Session Closed

April 30, 2026, 4:00 p.m. (JST)

arrow_right_alt Saturday 06 20 2026 21:22 PM JST

FY2025

Financial Results

1Q/FY2025 Financial Results

Shareholder Meeting

The 20th term Annual Shareholders Meeting, June 19, 2025

Notice of Convocation of the 20th Term Annual Shareholders Meeting (revised) (pdf 3.1MB）

Notice of Resolution (pdf 146KB)

Results of the Exercise of Voting Rights (pdf 186KB)

Amendment Report for Results of the Exercise of Voting Rights (pdf 236KB)

Questions and answers from shareholders

Annual Shareholders Meeting Script (549KB)

Product Meetings

IZERVAY Online Meeting (July 10, 2025)

Presentation Material (4.9MB)

FY2024

Financial Results

Full Year and 4Q/FY2024 Financial Results

3Q/FY2024 Financial Results

2Q/FY2024 Financial Results

1Q/FY2024 Financial Results

Integrated Report

Integrated Report 2024

Shareholder Meeting

The 19th term Annual Shareholders Meeting, June 20, 2024

Notice of Convocation of the 19th Term Annual Shareholders Meeting (pdf 2.9MB)

Notice of Resolution (pdf 145KB)

Results of the Exercise of Voting Rights (176KB)

Questions and answers from shareholders

Annual Shareholders Meeting Script (454KB)

Sustainability Meeting

Sustainability Meeting 2024 , February 21, 2025

Presentation Material (2.1MB)

On-demand Replay of Information Meeting

Meeting Script (5.0MB)

Product Meetings

ASP3082/Targeted Protein Degradation Online Meeting, September 27, 2024

Presentation Material (1.7MB)

On-demand Replay of Information Meeting

Meeting Script (2.8MB)

FY2023

Financial Results

Full Year and 4Q/FY2023 Financial Results

3Q/FY2023 Financial Results

2Q/FY2023 Financial Results

1Q/FY2023 Financial Results

Integrated Report

Integrated Report 2023

Shareholder Meeting

The 18th term Annual Shareholders Meeting, June 22, 2023

Notice of Convocation of the 18th Term Annual Shareholders Meeting (pdf 2.8MB)

Notice of Resolution (pdf 143KB)

Results of the Exercise of Voting Rights (pdf 185KB)

Questions and answers from shareholders

Annual Shareholders Meeting script (pdf 489KB)

Sustainability Meeting

Sustainability Meeting 2023, February 21, 2024

Presentation Material (3.4MB)

On-demand Replay of Information Meeting

Meeting Script (3.8MB)

Product Meetings

VYLOY (zolbetuximab) Online Meeting , March 29, 2024

Presentation Material (2.9MB)

IZERVAY Online Meeting , November 6, 2023

Presentation Material (784KB)

On-demand Replay of Information Meeting

Meeting Script (2.6MB)

VEOZAH (fezolinetant) Online Meeting, May 19, 2023

Presentation Material (3.9MB)

Patient & HCP Perspectives (video)

Other

Astellas Online Meeting (Acquisition of Iveric Bio), May 1, 2023

Presentation Material (824MB)

On-demand Replay of Information Meeting

Meeting Script

FY2022

Financial Results

Full Year and 4Q/FY2022 Financial Results

3Q/FY2022 Financial Results

2Q/FY2022 Financial Results

1Q/FY2022 Financial Results

Integrated Report

Integrated Report 2022

Shareholder Meeting

The 17th term Annual Shareholders Meeting, June 20, 2022

Notice of Convocation of the 17th Term Annual Shareholders Meeting (pdf 1.9MB)

Notice of Resolution (pdf 120KB)

Results of the Exercise of Voting Rights (pdf 67KB)

Questions and answers from shareholders

Annual Shareholders Meeting script (pdf 499KB)

R&D Meeting

R&D Meeting, December 9, 2022

Targeted Protein Degradation (734KB)

On-demand Replay of Information Meeting

Meeting Script (2,607KB)

Sustainability Meeting

Sustainability Meeting 2022, February 17, 2023

Presentation Material (1,712KB)

On-demand Replay of Information Meeting

Meeting Script (4,476KB)

Other

Media Briefing, March 27, 2023

Astellas’ Corporate-wide Digital Transformation Driven by Analytics (888KB)

On-demand Replay of Information Meeting

Meeting Script (3,278KB)

IR Meeting for Individual Investors (Hosted by Rakuten Securities, Inc.), December 14, 2022

Presentation Material (Eng. Translation) (1,566KB)

FY2021

Financial Results

Full Year and 4Q/FY2021 Financial Results

3Q/FY2021 Financial Results

2Q/FY2021 Financial Results

1Q/FY2021 Financial Results

Integrated Report

Integrated Report 2021

Shareholder Meeting

The 16th term Annual Shareholders Meeting, June 18, 2021

Notice of Convocation of the 16th Term Annual Shareholders Meeting (pdf 1.6MB)

Notice of Resolution (pdf 77KB)

Results of the Exercise of Voting Rights (pdf 83KB)

R&D Meeting

R&D Meeting, march 9, 2022

Initiatives for Gene Therapy (2,933KB)

Meeting Script (8,030KB)

R&D Meeting, December 7, 2021

NEW RESEARCH ORGANIZATION STRUCTURE (1,245KB)

Meeting Script (2,654KB)

Sustainability Meeting

Sustainability Meeting 2021, February 28, 2022

Presentation Material (946KB)

Meeting Script (4,467KB)

Product Meetings

ASP3082/Targeted Protein Degradation Online Meeting, September 27, 2024

Presentation Material (1.7MB)

On-demand Replay of Information Meeting

Meeting Script (2.8MB)

Other

Media Briefing, January 21, 2022

Digital Transformation of Astellas Pharma (3,351KB)

On-demand Replay of Information Meeting

Meeting Script (3,989KB)

Strategic Plan, May 26, 2021

CSP2021 (1,096KB)

FY2020

Financial Results

Full Year and 4Q/FY2020 Financial Results

3Q/FY2020 Financial Results

2Q/FY2020 Financial Results

1Q/FY2020 Financial Results

Integrated Report

Annual Report 2020

GRI Content Index

R&D Meetings

R&D Meeting, December 10, 2020

PROGRESS IN FOCUS AREA APPROACH (5,333KB)

FY2019

Financial Results

Full Year and 4Q/FY2019 Financial Results

3Q/FY2019 Financial Results

2Q/FY2019 Financial Results

1Q/FY2019 Financial Results

Integrated Report

Annual Report 2019 (3,544KB)

GRI Content Index (160KB)

R&D Meetings

R&D Meeting, December 10, 2019

Initiatives in immuno-oncology (3,894KB)

Product Meetings

Enfortumab vedotin Investor Meeting, October 1, 2019

Conference Call: enfortumab vedotin (1,235KB)

Other

Conference Call (Acquisition of Audentes), December 3, 2019

Conference Call: Acquisition of Audentes (960KB)

FY2018

Financial Results

Full Year and 4Q/FY2018 Financial Results

3Q/FY2018 Financial Results

2Q/FY2018 Financial Results

1Q/FY2018 Financial Results

Integrated Report

Annual Report 2018 (2,790KB)

GRI Content Index (121KB)

R&D Meetings

R&D Meeting, December 13, 2018

INITIATIVES IN CELL THERAPY (3,229KB)

Other

Strategic Plan, May 22, 2018

Strategic Plan 2018 (1,044KB)

Hosted by securities companies, January 8, 2019

J.P. Morgan Healthcare Conference (January 8, 2019 in local time) (733KB)

FY2017

Financial Results

Full Year and 4Q/FY2017 Financial Results

3Q/FY2017 Financial Results

2Q/FY2017 Financial Results

1Q/FY2017 Financial Results

Integrated Report

Annual Report 2017 (3,647KB)

GRI Content Index (119KB)

Product Meetings

Fezolinetant Investor Meeting, December 14, 2017

fezolinetant: A Novel Approach for Targeted Menopausal Symptom Relief (1,946KB)

Choose Language

Investor Relations Library

IR Calendar

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017